Aimed Bio에임드바이오
0009K0 · KOSDAQ · ₩0009K0 · 에임드바이오
₩19,850▼ ₩1,000 (4.80%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | |
|---|---|
| Revenue | ₩47B |
| Operating income | ₩21B |
| Net income | ₩5B |
| Net income to shareholders | ₩5B |
Balance sheet
| 2025 | |
|---|---|
| Total assets | ₩199B |
| Current assets | ₩179B |
| Cash and equivalents | ₩106B |
| Total liabilities | ₩6.4B |
| Current liabilities | ₩5.7B |
| Borrowings | ₩703M |
| Total equity | ₩193B |
| Shareholders' equity | ₩193B |
Cash flow
| 2025 | |
|---|---|
| Cash from operations | ₩18B |
| Capital spending | ₩354M |
| Free cash flow | ₩18B |
Consolidated where available. Amounts in won.
Also known as: Aimed Bio / 에임드바이오 / 0009K0 / KRX:0009K0
Source: KRX statistical information